cGMP cell bank Manufacturing

High-Quality Mammalian Suspension Cell Banks in 3 months after transfection

The quality of Master Cell Banks (MCB) and Working Cell Banks (WCB) are paramount for the development and production of biologics. The robustness and reliability of the cell bank significantly influence the overall quality and consistency of the final biologic products.

Thanks to our proprietary transposon-based technology, we are able to start MCB manufacturing in 3 months after a transfection with a gene of interest.

Since 2010 we offer GMP cell bank production fully integrated into our cell line and process development services with additional storage and characterization services of cell banks.​

In our GMP-compliant facilities, we adhere to the pharmaceutical quality management system (QMS) for the manufacturing and release of MCB and WCB, following ICH, PIC/S and EU-GMP (EudraLex) guidelines.

HOW WE CAN HELP

Our cleanroom facility
in Switzerland

  • Operates in full compliance with GMP.
  • Is fully dedicated to mammalian cell lines.
  • Utilizes only animal component/origin-free reagents. 
  • Focuses on generating cell banks for GMP manufacturing, including innovative and biosimilar therapeutics, antigen-based vaccines, viral vectors for the cell and gene therapy and other biologics.
  • Is monitored and under Alarm Management System .
  • Is Swissmedic certified (the Swiss Health Authorities, equivalent to EMA).